THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 99 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,180 | +39.4% | 252,609 | +67.1% | 0.02% | +108.3% |
Q2 2023 | $1,564 | +379.8% | 151,134 | +403.6% | 0.01% | +200.0% |
Q1 2023 | $326 | +88.4% | 30,008 | +94.8% | 0.00% | +100.0% |
Q4 2022 | $173 | -99.9% | 15,407 | -43.5% | 0.00% | -33.3% |
Q3 2022 | $276,000 | +72.5% | 27,265 | +54.1% | 0.00% | +50.0% |
Q2 2022 | $160,000 | -33.3% | 17,698 | -18.5% | 0.00% | +100.0% |
Q4 2021 | $240,000 | -16.7% | 21,711 | -44.3% | 0.00% | 0.0% |
Q3 2021 | $288,000 | +146.2% | 38,968 | +384.6% | 0.00% | 0.0% |
Q2 2021 | $117,000 | -84.4% | 8,042 | -81.0% | 0.00% | -75.0% |
Q4 2020 | $750,000 | +114.9% | 42,230 | +153.7% | 0.00% | +33.3% |
Q2 2020 | $349,000 | -46.4% | 16,643 | -40.9% | 0.00% | -50.0% |
Q1 2020 | $651,000 | +317.3% | 28,178 | +366.9% | 0.01% | +500.0% |
Q4 2019 | $156,000 | 0.0% | 6,035 | -12.4% | 0.00% | 0.0% |
Q1 2019 | $156,000 | +20.0% | 6,890 | +28.9% | 0.00% | 0.0% |
Q1 2018 | $130,000 | -58.1% | 5,347 | -41.0% | 0.00% | -66.7% |
Q3 2017 | $310,000 | +31.4% | 9,061 | +52.8% | 0.00% | +50.0% |
Q2 2017 | $236,000 | +16.8% | 5,931 | +8.1% | 0.00% | 0.0% |
Q1 2017 | $202,000 | -70.6% | 5,488 | -74.5% | 0.00% | -66.7% |
Q4 2016 | $686,000 | – | 21,510 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
Baupost Group | 7,419,226 | $64,028 | 1.23% |
Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |